Taiwan Liposome Company Ltd Receivables Turnover Ratio (TLC), from the fourth quarter 2020 to the fourth quarter 2019 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Taiwan Liposome Company Ltd   (NASDAQ: TLC)
 

Taiwan Liposome Ltd Accounts Receivables Turnover Ratio from the fourth quarter 2020 to the fourth quarter 2019

Quarterly Results, Trends, Rankings, Statistics


Taiwan Liposome Company Ltd 's ability to collect accounts receivable sequentially worsen to 10.97, indicating more challenging environment then in the third quarter 2020, but still, it is a far cry from any concerns. Taiwan Liposome Ltd 's Accounts Receivable average collection period in the Dec 31 2020 quarter, has increased to 33 days, from 20 days, in the 0 quarter.

If we take a look into Healthcare sector 526 other companies have achieved higher receivables turnover ratio. While total ranking has deteriorated relative to the period ending Dec 31 2020 from 3196 to 3740.

What is Receivable Turnover Ratio?
What is Taiwan Liposome Company Ltd Selling?


What is Receivable Turnover Ratio?





TLC Receivables Turnover Ratio (Dec 31 2020)
IV. Quarter
0
III. Quarter
0
II. Quarter
0
I. Quarter
(Dec 31 2019)
IV. Quarter
Y / Y Receivable Change -34.58 % -34.58 % -34.58 % -34.58 % 65.9 %
Y / Y Revenue Change -48.08 % - - - 243.42 %
Receivable Turnover Ratio (TTM) 10.97 18.66 16.71 15.13 13.82
TLC's Total Ranking # 3740 # 3196 # 3724 # 0 # 3967
Accounts Receivable average collection period days 33 20 22 24 26
Seq. Receivable Change 0 % 0 % 0 % -34.58 % 0 %
Seq. Revenue Change - - - - -


Receivable Turnover Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 210
Healthcare Sector # 527
Overall Market # 3740

Receivable Turnover Ratio Statistics
High Average Low
1.56 1.04 0.75
(Dec 31 2019)   (Dec 31 2020)






Financial Statements
Taiwan Liposome Ltd 's Accounts Receivable $ 0 Millions Visit TLC's Balance sheet
Taiwan Liposome Ltd 's Sales TTM $ 4 Millions Visit TLC's Income Statement
Sources of TLC's Revenues Visit TLC's Sales by Geography

Other Accounts Receivable Turnover Ratios
Major Pharmaceutical Preparations Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
TLC's Receivable Turnover Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
TLC's Growth Rates TLC's Roa TLC's Inventory Turnover Ratio TLC's Dividend Comparisons
TLC's Profitability Ratios TLC's Roi TLC's Asset Turnover Ratio TLC's Dividend Growth
TLC's Valuation Ratios TLC's Roe TLC's Financial Strength Ratios TLC's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Dec 31 2020, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Dec 31 2020 Receivable at quarter ending Dec 31 2020
Arvinas Inc   30.08 $ 25.900  Millions$ 0.861  Millions
Brookdale Senior Living Inc   29.96 $ 3,588.729  Millions$ 119.769  Millions
Ernexa Therapeutics Inc   28.40 $ 5.800  Millions$ 0.204  Millions
Assembly Biosciences Inc   28.28 $ 79.105  Millions$ 2.798  Millions
Hqda Elderly Life Network Corp.  26.78 $ 0.945  Millions$ 0.035  Millions
Nutriband Inc   23.92 $ 0.944  Millions$ 0.039  Millions
Lensar Inc   23.76 $ 26.382  Millions$ 1.110  Millions
U S Physical Therapy Inc  23.04 $ 422.969  Millions$ 18.354  Millions
Uniqure N v   22.67 $ 37.514  Millions$ 1.655  Millions
Harrow Inc   21.95 $ 48.871  Millions$ 2.226  Millions
Scorpius Holdings inc   21.04 $ 2.948  Millions$ 0.140  Millions
Cardax Inc   20.81 $ 0.539  Millions$ 0.026  Millions
Ethema Health Corporation   20.71 $ 0.339  Millions$ 0.016  Millions
Advanced Container Technologies Inc   20.49 $ 2.228  Millions$ 0.109  Millions
Dbv Technologies S a   20.23 $ 11.276  Millions$ 0.558  Millions
Durect Corp  19.63 $ 30.111  Millions$ 1.534  Millions
Fonar Corporation  19.49 $ 78.814  Millions$ 4.043  Millions
Therapeutic Solutions International Inc   19.46 $ 0.063  Millions$ 0.003  Millions
China Pharma Holdings Inc  19.37 $ 10.866  Millions$ 0.561  Millions
Xenon Pharmaceuticals Inc   18.83 $ 32.166  Millions$ 1.709  Millions
Cv Sciences Inc   18.81 $ 24.429  Millions$ 1.299  Millions
Catalyst Pharmaceuticals Inc   18.65 $ 119.073  Millions$ 6.385  Millions
Ibio inc   17.76 $ 2.331  Millions$ 0.131  Millions
Fulcrum Therapeutics Inc   17.65 $ 8.823  Millions$ 0.500  Millions
Emmaus Life Sciences Inc   17.55 $ 23.167  Millions$ 1.320  Millions
Delcath Systems Inc   17.51 $ 1.646  Millions$ 0.094  Millions
Semler Scientific inc   17.50 $ 38.603  Millions$ 2.207  Millions
Ascendis Pharma A  16.76 $ 7.934  Millions$ 0.473  Millions
Neurometrix Inc   16.76 $ 7.378  Millions$ 0.440  Millions
Electrocore Inc   16.69 $ 3.496  Millions$ 0.210  Millions

Date modified: 2026-09-18T13:11:04+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.